NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it is entering the next phase of its planned 510(k) submission to the FDA. The Company has successfully completed subject screening for its Pharmacokinetic (PK) Study and will begin dosing and sampling study subjects today. INBS' PK study is a key step towards the Company's planned ...

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the implementation of a strategic and comprehensive reorganization and productivity plan to support the Company's global growth initiatives. Harry Simeonidis, President and CEO at INBS, commented, "This strategic realignment will refocus priorities to better serve our global markets, enh ...

The addition of the European transport and infrastructure solutions provider to INBS' growing number of accounts shows an increasing interest in its innovative technology within the transport and infrastructure sectors. INBS' existing customer, VANTEC Europe Limited ("VANTEC"), is a global provider of transportation and logistics solutions with 12 operations throughout the UK. VANTEC has used INBS' system since 2021, with Diane Elgar, Head of Human Resources and Training at VANTEC Europe Limited, previously ...

NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in the Sidoti Small-Cap Conference being held virtually June 12-13, 2024. Presentation Details Date: Wednesday, June 12, 2024 Time: 4:00 p.m. Eastern Time Registration/Webcast Link: https://sidoti.zoom.us/webinar/register/WN_BB5QumW3TK2N56X7MOPj ...

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine ...

NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful recruitment and commencement of screening for subjects in its pharmacokinetic (PK) study, a critical component of the Company's FDA 510(k) regulatory pathway for clearance. Harry Simeonidis, President and CEO at INBS, commented, "As we navigate the FDA 510(k) regulatory pa ...

文章核心观点 - 公司在英国市场取得快速增长,总收入同比增长193% [2] - 公司在英国市场的客户数量超过400家,并在过去12个月内新增111个客户 [4] - 公司的快速非侵入性毒品检测解决方案受到市场欢迎,有望在美国市场推出后取得成功 [4] - 公司的解决方案能够有效防止毒品检测作弊,满足市场需求 [5][6][7] 关键指标总结 财务指标 - 截至2024年3月31日的9个月期间,公司总收入约2.38亿美元,同比增长193% [2] - 在9个月期间,毛利率较高的试剂盒收入占总收入的49% [3] 业务指标 - 截至2024年3月31日,公司在英国为超过400家客户提供服务,涵盖15个行业 [4] - 在截至2024年3月31日的12个月内,公司新增111个客户 [4] - 公司在英国的市场份额不断提升,反映出对有效检测解决方案的需求日益增加 [5]

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today unveiled key performance indicators from its United Kingdom operations. These indicators have contributed to the Company's growth as the drug screening industry continues to combat drug test cheating and searches for simpler, faster, non-invasive, and more cost-effective solutions. For the nine mo ...

The Health & Safety Event has become a crucial meeting place for individuals dedicated to maintaining safe and efficient workplaces. It served as a prominent stage for INBS to demonstrate its innovative drug screening technology. According to the event website, 77% of those who attend the show are key decision-makers, with 88% considering the show essential to their business operations. NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 18, 2024 INTELLIGENT BIO SOLUTIONS INC. (Exact name of registrant as specified in its charter) Delaware 001-39825 82-1512711 (State of Incorporation) (Commission File Number) (IRS employer identification no.) 142 West, 57 Street, 11th Floor New York, NY 10019 (Address of principal executi ...